Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Filler

Showing results (21-30 of 340) with videos related to

Pageof 34
Sort By:
Expert Opinion on Drug Safety|August 11, 2007
Safety considerations with mycophenolate sodiumGuido Filler, Ilan Buffo
Pediatric Nephrology (Berlin, Germany)|December 9, 2017
Educational review: measurement of GFR in special populationsGuido Filler, Misan Lee
Pediatric Transplantation|June 9, 2024
Should We Switch to the U25 Creatinine and CysC eGFR to Monitor Pediatric Kidney Transplant Recipients?Guido Filler, Dougenie Emile
American Journal of Nephrology|December 23, 2016
Is Fibroblast Growth Factor 23 the New Biomarker for Cardiovascular Mortality in Chronic Kidney Disease Patients?Guido Filler, Christopher McIntyre
Pediatric Transplantation|April 4, 2017
Improving long-term outcomes after pediatric renal transplantation by addressing dyslipidemiaGuido Filler, Mara Medeiros
Pediatric Nephrology (Berlin, Germany)|May 26, 2025
Toward lean body weight- and ECV-based dosing of burosumab: eliminating apparent sex differences in XLH therapyGuido Filler, Funmbi Babalola
The Journal of Pediatrics|October 20, 2010
Variability of the pediatric subspecialty workforce in CanadaGuido Filler, Bruno Piedboeuf,
Clinical Kidney Journal|September 16, 2024
A step forward for estimating GFR in young adultsGuido Filler, Mara Medeiros
Pediatric Transplantation|November 25, 2016
Is a reduction in cystometric bladder capacity in anuric infants post-renal transplant really no big deal?Guido Filler, Sumit Dave
Pediatric Nephrology (Berlin, Germany)|July 17, 2004
To what extent does the understanding of pharmacokinetics of mycophenolate mofetil influence its prescriptionGuido Filler, Nathalie Lepage
Pageof 34

Showing results (21-30 of 340) with videos related to

Sort By:
Pageof 34
Expert Opinion on Drug Safety|August 11, 2007
Safety considerations with mycophenolate sodiumGuido Filler, Ilan Buffo
Pediatric Nephrology (Berlin, Germany)|December 9, 2017
Educational review: measurement of GFR in special populationsGuido Filler, Misan Lee
Pediatric Transplantation|June 9, 2024
Should We Switch to the U25 Creatinine and CysC eGFR to Monitor Pediatric Kidney Transplant Recipients?Guido Filler, Dougenie Emile
American Journal of Nephrology|December 23, 2016
Is Fibroblast Growth Factor 23 the New Biomarker for Cardiovascular Mortality in Chronic Kidney Disease Patients?Guido Filler, Christopher McIntyre
Pediatric Transplantation|April 4, 2017
Improving long-term outcomes after pediatric renal transplantation by addressing dyslipidemiaGuido Filler, Mara Medeiros
Pediatric Nephrology (Berlin, Germany)|May 26, 2025
Toward lean body weight- and ECV-based dosing of burosumab: eliminating apparent sex differences in XLH therapyGuido Filler, Funmbi Babalola
The Journal of Pediatrics|October 20, 2010
Variability of the pediatric subspecialty workforce in CanadaGuido Filler, Bruno Piedboeuf,
Clinical Kidney Journal|September 16, 2024
A step forward for estimating GFR in young adultsGuido Filler, Mara Medeiros
Pediatric Transplantation|November 25, 2016
Is a reduction in cystometric bladder capacity in anuric infants post-renal transplant really no big deal?Guido Filler, Sumit Dave
Pediatric Nephrology (Berlin, Germany)|July 17, 2004
To what extent does the understanding of pharmacokinetics of mycophenolate mofetil influence its prescriptionGuido Filler, Nathalie Lepage
Pageof 34